For instance, in South Africa, genetic testing for the BRCA1 and BRCA2 genes in breast cancer has been implemented at the primary healthcare level for over two decades, with plans to upscale to a multigene next-generation sequencing (NGS) panel (120). The gene discussed is BRCA2; the disease is breast carcinoma.